Consequently, compared to individual protein molecules, a clinical model based on the combined expression of Ki67, Her-2, and MutP53 proteins might provide a more accurate and comprehensive reflection of CRC progression and prognosis. This evidence concerns the gene MKI67 and colorectal carcinoma.